FIFTH SUPPLEMENTAL INDENTURESupplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 3rd, 2013 Company Industry JurisdictionFIFTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Fifth Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
FIFTH SUPPLEMENTAL INDENTURESupplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 3rd, 2013 Company Industry JurisdictionFIFTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Fifth Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).